MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'depressive disorder'. Sat, 03 Sep 2011 02:25:59 +0100 http://www.medworm.com/index.php?rid=4709217&cid=t_232090_93_f&fid=36531&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FJeffreyMD%2F%7E3%2F-8IPlmhTe1I%2F This morning I posted the following on my tumblr1 account (link to original post): MDD is associated with a mortality rate of 15% — suicide. 50% of people with MDD receive no treatment. What other disease has a 15% mortality rate, yet we do so little to get them help?   It was subsequently reblogged by myvonne with her “rant” (her words). Here is the link to her full response, unadulterated by my annotations. Now, I don’t know myvonne at all. It appears she reblogged me through another reblog. So she may or may not ever read this response. But if she does, I want her to know this: 1. I understand that your own personal life experiences have shaped whatever strong views you hold that must have fueled that rant. 2. If we, the medical profession, have wronged you or your loved ... JeffreyMD.com blogs http://www.medworm.com/rss/comments.php?id=4709217 Thu, 14 Apr 2011 01:36:05 +0100 4709217 http://www.medworm.com/index.php?rid=4361249&cid=t_232090_135_f&fid=35247&url=http%3A%2F%2Fmyjourneywithaids.wordpress.com%2F2011%2F01%2F17%2Fthank-you-candy-crowley-and-state-of-the-union%2F “I think you might have bipolar disorder,” he (psychiatrist) said. “Oh, thank God,” I answered. Surprise registered on his face. “I don’t think I’ve ever had that reaction before.” “No, I am so relieved,” I said. “Now that we know what it is, we can fix it.” Andrea Ball (Statesman.com) – Jared Loughner and the [...] (Source: My journey with AIDS) My journey with AIDS blogs http://www.medworm.com/rss/comments.php?id=4361249 Mon, 17 Jan 2011 21:22:55 +0100 4361249 http://www.medworm.com/index.php?rid=3973117&cid=t_232090_150_f&fid=35777&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2Fb2h0UB6N-As%2F Rise and shine, everyone. Another day is upon us. But this is a good thing. As one of our favorite sages, the Morning Mayor, used to say: Every brand new day should be unwrapped like a precious gift. While you tug on the ribbon, we will brew the mandatory cup of stimulation and poke around for interesting items. Here, in fact, are a few to help you get started. Have a good one and stay in touch… Roche Rules Out Merging R&D With Genentech (Reuters) Abbott To Close Canadian Baby Formula Plant (Brockville Recorder & Times) China’s BGI And Merck Form Alliance (Bio-IT World) Abbott Fights To Keep Meridia Diet Pill On The Market (Reuters) K-V Pharmaceutical Secures A $20M Loan (Fox Business) Genentech CEO Resigns From Dendreon Board (Xconomy) Cell Therapeutics Appeals FDA R... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=3973117 Wed, 15 Sep 2010 11:51:18 +0100 3973117 http://www.medworm.com/index.php?rid=3973119&cid=t_232090_151_f&fid=35805&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Ftwelvestepfacilitation%2FwAgT%2F%7E3%2F3XEILuaqAG4%2F Going slower is better. Patients’ risks for relapse increase when lithium or antipsychotic medications are discontinued rapidly rather than gradually. To compare rapid (1–7 days) versus slow ( 14 days) discontinuation of antidepressants, researchers in Sardinia followed 398 patients with recurrent major depressive disorder (n=224), panic disorder (n=75), bipolar II disorder (n=62), or bipolar I disorder (n=37). Follow-up lasted at least 1 year (mean, 2.8 years; mean length of antidepressant treatment, 8.5 months). In this observational study, the treating clinicians or the patients had chosen to discontinue medications when patients were clinically well; antidepressants were withdrawn rapidly in 188 patients and gradually in 210. Rapid discontinuation was associated with a signific... Twelve Step Facilitation.com blogs http://www.medworm.com/rss/comments.php?id=3973119 Wed, 08 Sep 2010 11:49:32 +0100 3973119 http://www.medworm.com/index.php?rid=2948359&cid=t_232090_109_f&fid=38950&url=http%3A%2F%2Fwww.shockmd.com%2F2009%2F11%2F01%2Filluminate-depression%2F QUEST on KQED Public Media. A very good video about the symptoms of depression and antidepressants. It shows how antidepressants are supposed to work with nice graphics. The next topic is Transcranial Magnetic Stimulation or TMS. An option when medication isn’t working. One of 9 options for treatment resistant depression. A treatment is shown with some explanation of how it works. The FDA has approved TMS for depression, but is still costs a lot of money. Personally I am not impressed with the evidence of the efficacy of TMS for depression Also shown is a way to stimulate rodent brains with light using light sensitive proteins in rodents, called optogenetics. It makes a nice model for activity in the brain during depression. It’s an example of how new tools and research are sh... Dr Shock MD PhD blogs http://www.medworm.com/rss/comments.php?id=2948359 Sun, 01 Nov 2009 13:26:26 +0100 2948359 http://www.medworm.com/index.php?rid=2287230&cid=t_232090_109_f&fid=34750&url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2009%2F03%2F23%2Ffda-approves-symbyax-for-treatment-resistant-depression%2F Today, the U.S. Food and Drug Administration (FDA) approved Symbyax for the acute treatment of treatment-resistant depression (TRD). It is the first drug approved for this indication. Symbyax is a combination pill that combines olanzapine (Zyprexa) and fluoxetine HCl (a long-acting form of Prozac) in a single capsule. Symbyax is manufactured by Eli Lilly and Company. According to the company’s press release: The new Symbyax TRD indication is for acute treatment of adult patients with major depressive disorder who have not responded to two separate trials of different antidepressants of adequate dose and duration in their current episode. Zyprexa, in combination with fluoxetine, is now approved for the acute treatment of TRD in adults. Symbyax was the first drug approved by the FD... World of Psychology blogs http://www.medworm.com/rss/comments.php?id=2287230 Mon, 23 Mar 2009 21:02:51 +0100 2287230 http://www.medworm.com/index.php?rid=4060689&cid=t_232090_109_f&fid=34859&url=http%3A%2F%2Fblog.davemsw.com%2Farchives%2F2009%2F03%2Fmood_swings_are_normal.php Image via Wikipedia We have become a medicating culture. If we don't like how we feel, we can take a pill to feel better. Kellen Von Houser, MA, LPC, in her blog Kellevision says it boldly. "My concern is for people who are actually experiencing the normal emotions of life, labeling them "mood swings" and trying to medicate their discomfort away. My concern is for doctors who participate in this and validate it. My concern is for teaching people that emotions can be "negative" and undesirable. That they are "bad" in some way and should be eliminated, by chemical intervention or any other means. This is not a message we want to send. Emotions are what make us human. And expressing them is what keeps us sane. " In this world, shrewd advertisers manipulate our moods to overwhelm our self... Ψ Dare To Dream... blogs http://www.medworm.com/rss/comments.php?id=4060689 Wed, 11 Mar 2009 18:03:25 +0100 4060689 http://www.medworm.com/index.php?rid=4060691&cid=t_232090_109_f&fid=34859&url=http%3A%2F%2Fblog.davemsw.com%2Farchives%2F2008%2F12%2Fclients_not_practitioners_make_therapy_work.php Image via Wikipedia I have been really enjoying my access to a large number of professional journals over the past couple years. Working at a teaching hospital definitely has it's academic perks. I've been particularly gratified to see a growing sophistication in research methods, creative approaches and a maturing view of results. Until recently, practice based research articles have often taken the form of providing some support for a therapist preferred approach to therapy. I can understand that, for I am too, highly invested in how I do and why I do it. But many if not most therapy based research describes a new fangled therapy with a new name. This sort of research seems to me to be more self-serving and contributing to a ever fracturing of psychological science. There are so many ... Ψ Dare To Dream... blogs http://www.medworm.com/rss/comments.php?id=4060691 Sun, 28 Dec 2008 18:27:48 +0100 4060691 http://www.medworm.com/index.php?rid=2018102&cid=t_232090_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F475641626%2F The FDA sent the drugmaker a warning letter after learning that a sales rep this past January suggested to physician that the Seroquel antipsychotic could be used to treat major depressive disorder, which would be an unapproved use. After getting the pitch, the doc requested info to support the claim, and AstraZeneca mailed a thick packet that summarized research studies of Seroquel in depression, according to the FDA, which characterized the move as creating a new ‘intended use.’ According to the FDA letter, AstraZeneca’s material indicated the drugmaker did not recommend Seroquel for unapproved uses, but the FDA maintained the disclaimer was “insufficient to mitigate the promotion” of a new use (here is the letter and the material sent to the doc). An Astra... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=2018102 Fri, 05 Dec 2008 12:02:13 +0100 2018102 http://www.medworm.com/index.php?rid=4060705&cid=t_232090_109_f&fid=34859&url=http%3A%2F%2Fblog.davemsw.com%2Farchives%2F2008%2F08%2Fintroducing_pete_feigal_inspirational_speaker.php Pete Feigal sent me another set of stories now posted to Dare To Dream Forums. Pete has been a regular contributor. He is now blind, mostly wheelchair bound, but still one of the most inspirational speakers I've ever heard on the topic of recovery from disability. Pete Feigal has been battling clinical depression for 30 years, and MS for the last 19. He has spoken nationally over 1400 times in the last 11 years for schools, colleges, prisons, corporations, churches, medical professionals and police forces around the nation. He is a native Minnesotan and has been, in his checkered past, a professional Shakespearian actor, an aviation and motorcycle artist, and a motorcycle drag racer. He describes his newest contributions. ""Why There Are No 'Whys?'" came from all of the senseless killi... Ψ Dare To Dream... blogs http://www.medworm.com/rss/comments.php?id=4060705 Thu, 21 Aug 2008 01:38:25 +0100 4060705 http://www.medworm.com/index.php?rid=4060706&cid=t_232090_109_f&fid=34859&url=http%3A%2F%2Fblog.davemsw.com%2Farchives%2F2008%2F08%2Fis_sadness_the_same_as_depression.php This article examines the assumption that major depression is a specific illness, that it is rapidly increasing, and that a medical response is justified. I argue that major depression is not a natural entity and does not identify a homogenous group of patients. The apparent increase in major depression results from: confusing those who are ill with those who share their symptoms; the surveying of symptoms out of context; the benefits that accrue from such a diagnosis to drug companies, researchers, and clinicians; and changing social constructions around sadness and distress. Standardized medical treatment of all these individuals is neither possible nor desirable. The major depression category should be replaced by a clinical staging strategy that acknowledges the continuous distribution... Ψ Dare To Dream... blogs http://www.medworm.com/rss/comments.php?id=4060706 Sun, 17 Aug 2008 19:04:24 +0100 4060706 http://www.medworm.com/index.php?rid=4060722&cid=t_232090_109_f&fid=34859&url=http%3A%2F%2Fblog.davemsw.com%2Farchives%2F2008%2F05%2Fdepression_out_of_the_shadows.php This looks like a good one. I'm going to watch for sure. You can even buy the DVD now. "DEPRESSION: Out of the Shadows is a 90-minute documentary about recognizing, treating, and researching depression. DEPRESSION: Out of the Shadows . Video Preview | PBS A lot of Americans are keeping an important, possibly deadly secret. The National Institute of Mental Health reports that approximately 18.8 million American adults have a depressive disorder. The disease is not discriminating, seeping into all age, race, gender, and socioeconomic groups. Depression stalls careers, strains relationships, and sometimes ends lives. So if this many people are living with the disease, why the silence? DEPRESSION: Out of the Shadows is a multi-dimensional PBS project that explores the disease's complex ... Ψ Dare To Dream... blogs http://www.medworm.com/rss/comments.php?id=4060722 Thu, 15 May 2008 02:22:22 +0100 4060722 http://www.medworm.com/index.php?rid=1329205&cid=t_232090_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F258378897%2F Close to 10 percent of men and women in America are reportedly taking drugs to combat depression. How did a once rare condition become so common? That’s the question asked in a lengthy piece in a recent issue of Scientific American. And the author suggests there are two overarching reasons… 1 - Many docs conflate conventional sadness - as from the loss of a loved one or a life-changing event such as a divorce - with the more serious and life-quashing condition of clinical depression. 2 - A second contributing factor is a change in the standard diagnostic guide, which caused many milder mental ailments to fall under the seemingly neutral label of “disorder.” “Depression, once considered a rare disease usually associated with elderly women, is overwhelmingly the menta... Pharmalot blogs http://www.medworm.com/rss/comments.php?id=1329205 Wed, 26 Mar 2008 15:32:41 +0100 1329205 http://www.medworm.com/index.php?rid=4060727&cid=t_232090_109_f&fid=34859&url=http%3A%2F%2Fblog.davemsw.com%2Farchives%2F2008%2F03%2Fpsychiatric_comorbidity_of_internet_addiction_in_c.php While still excluded from the DSM IV TR, Internet addiction has graduated to a subject worthy of research. And not surprisingly, like all other addictive behaviors, what I like to call "temporary feel goods", are associated with a lot of other diagnoses. Avoiding negative emotions has serious consequences, beyond even addictions. CNS Spectrums "Internet addiction were more likely to have MDD, dysthymic disorder, social phobia and adult ADHD than their unaffected counterparts. Adult ADHD is the most significant predictor for Internet addiction, followed by depressive disorders. Social phobia, however, was not correlated with Internet addiction in our sample after controlling for depressive disorders and adult ADHD. Further, depressive disorders and Internet addiction were associated in th... Ψ Dare To Dream... blogs http://www.medworm.com/rss/comments.php?id=4060727 Sat, 01 Mar 2008 17:18:23 +0100 4060727 http://www.medworm.com/index.php?rid=4060731&cid=t_232090_109_f&fid=34859&url=http%3A%2F%2Fblog.davemsw.com%2Farchives%2F2007%2F12%2Fthe_process_of_grieving.php The Journal of the American Medical Association [February 21, 2007--Vol 297, No. 7] published an important article on grief, Maciejewski et al (2007). While it's hardly definitive research, it represents an exciting trend in research that I've seen in recent years. Researchers seem more willing to take some risks with the rigor of their research models to produce information that is immediately relevant to practice. While, we are a long way from having clear guidance towards an evidenced-based practice in psychotherapy, testing models in active use in the field provides immediately useful information. Grief is one of the most common issues that emerge in psychotherapy. Grief unfolds in a purposive and meaningful way from the first awareness of loss. The grief process guides us through the... Ψ Dare To Dream... blogs http://www.medworm.com/rss/comments.php?id=4060731 Fri, 28 Dec 2007 03:23:22 +0100 4060731 http://www.medworm.com/index.php?rid=1047610&cid=t_232090_97_f&fid=35050&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmaGazette%2F%7E3%2F189406329%2Ffda_approves_abilify_as_add-on_for_major_depression.html Earlier this month the U.S Food and Drug Administration approved Abilify for the treatment of schizophrenia in teens and have now expanded that approval to include patients with major depressive disorder.Approved in 2002 for schizophrenia in adults and for adults suffering from bipolar manic episodes, Bristol-Myers Squibb states that Abilify is the first drug approved as an adjunctive treatment for major depressive disorder for patients needing more than just antidepressants."The approval of this new add-on treatment option is critical for adults suffering from depression who cannot find sufficient relief for their symptoms with antidepressants alone," commented Madhukar Trivedi, M.D., of the University of Texas Southwestern Medical School in Dallas.Supplemental approva... PharmaGazette blogs http://www.medworm.com/rss/comments.php?id=1047610 Fri, 23 Nov 2007 15:00:13 +0100 1047610 http://www.medworm.com/index.php?rid=4060741&cid=t_232090_109_f&fid=34859&url=http%3A%2F%2Fblog.davemsw.com%2Farchives%2F2007%2F10%2Fthe_role_of_shame_in_therapy.php BPS RESEARCH DIGEST reviews recent research articles in professional journals. It's a good place to try to keep up with the literature. It has been a pleasant surprise indeed that many psychodynamic principles have recently demonstrated in research. Unconscious motivations, emotion based early learning have repeatedly been demonstrated. Now I was pleased to find the begins of a research demonstration of one of the most important insights into the obstacles for change that emerge in therapy: the labeling effects of diagnosis and the self-destructive nature of shame. "Psychological outcome research tends to follow the same model, matching therapy to diagnosis. The client is again little more than the holder of the diagnosis and the subject of the therapy: their individual decisions and pers... Ψ Dare To Dream... blogs http://www.medworm.com/rss/comments.php?id=4060741 Fri, 19 Oct 2007 01:47:25 +0100 4060741 http://www.medworm.com/index.php?rid=4060744&cid=t_232090_109_f&fid=34859&url=http%3A%2F%2Fblog.davemsw.com%2Farchives%2F2007%2F09%2Fapproaching_the_challenge_of_bipolar_depression_results_from_step-bd.php There is some major progress in the treatment of persons with Bipolar DO - Mixed episodes. Bipolar DO-Mixed is characterized by less serious manic symptoms, or hypomania, and significant depressive symptoms occuring at the same time. As you might expect, having a high energy level, little impulse control, impaired judgment and significant depression is a miserable condition, prone to substance abuse, suicide ideation and serious attempts. Persons with BPDO-Mixed are more prevalent in my practice than any other subtype of the disorder. That fact could be an artifact of primary finding of the following studies. Anti-depressants, when combined with mood stabilizers such as Lithium or Depakote, or atypical anti-psychotic medications like Abilify or Seroquel have been found to provide no more ... Ψ Dare To Dream... blogs http://www.medworm.com/rss/comments.php?id=4060744 Sat, 22 Sep 2007 03:37:03 +0100 4060744 http://www.medworm.com/index.php?rid=4060752&cid=t_232090_109_f&fid=34859&url=http%3A%2F%2Fblog.davemsw.com%2Farchives%2F2007%2F08%2Fabout_eight_percent_of_us_experiences_depression_e.php SAMHSA released incidence statistics for depression over the the years of 2004 and 2005. Statistics were sorted by age and state and included all individuals who experienced at least one major depressive episode (MDE) in the past year. Youths aged 12 to 17 had a higher rate of incidence at 8.88 percent. Adults aged 18 or older were measured at 7.65 percent. But thats not all. The data demonstrates a confusing variation in the rate by state. "Among 12 to 17 year olds, rates of past year MDE were among the highest in Idaho (10.37 percent) and Nevada (10.28 percent) and among the lowest in Louisiana (7.19 percent) and South Dakota (7.40 percent) Rates of past year MDE among adults aged 18 or older were among the highest in Utah (10.14 percent) and Rhode Island (9.88 percent) and among the ... Ψ Dare To Dream... blogs http://www.medworm.com/rss/comments.php?id=4060752 Sat, 04 Aug 2007 03:49:41 +0100 4060752 http://www.medworm.com/index.php?rid=4060754&cid=t_232090_109_f&fid=34859&url=http%3A%2F%2Fblog.davemsw.com%2Farchives%2F2007%2F07%2Fsupport_vs_corumination.php Here is another example of how the media doesn't really do much to enhance understanding of mental health. A researcher releases his results for peer review and integration into professional knowledge. A reporter sees the alarmist headlines and shares it with the general public with the first line of the article: "A researcher at the University of Missouri-Columbia has found that girls who talk very extensively about their problems with friends are likely to become more anxious and depressed." The danger here is that the average parent will see this as a reason to intrude into their daughter's friendships in hopes of preventing "co-rumination" by interrupting an unhealthy peer relationship. That could be a very destructive approach and may in fact drive those relationships "underground", ... Ψ Dare To Dream... blogs http://www.medworm.com/rss/comments.php?id=4060754 Mon, 16 Jul 2007 15:48:23 +0100 4060754 http://www.medworm.com/index.php?rid=4060778&cid=t_232090_109_f&fid=34859&url=http%3A%2F%2Fblog.davemsw.com%2Farchives%2F2007%2F01%2Fantidepressants_and_suicide.php Anyone taking or contemplating anti-depressants for treatment of depression have been concerned about the blackbox warnings from the FDA. The FDA has issued blanket warnings to anyone considering or taking anti-depressants that they may actually induce suicidal thinking. The truth is that there is still very little and conflicting information about the risks. Highlighting the risks in the way the FDA did by issuing a blackbox warning has been controversial. The problem is that the risks have been assessed in only a few studies and it is not clear what is happening. The other problem is that anti-depressants also treat and prevent suicidal behavior. Not taking an anti-depressant when you need one can also be a grave risk. There is concern within the psychiatric and advocate community tha... Ψ Dare To Dream... blogs http://www.medworm.com/rss/comments.php?id=4060778 Sat, 20 Jan 2007 18:03:49 +0100 4060778 http://www.medworm.com/index.php?rid=4060797&cid=t_232090_109_f&fid=34859&url=http%3A%2F%2Fblog.davemsw.com%2Farchives%2F2006%2F10%2Fcan_chat_room_support_and_phon.php On-line education with chat room support for eating disorders, on-line self-help support for depression, on-line treatment for panic disorder, on-line and phone-based help for sexual problems, and phone therapy with miscarriage sufferers have been recently studied as reported in recent journal articles. While this is exciting and concerning at the same time, these studies is only a beginning of a new area of research in providing mental health services. I'm committed to having some part in this process and hope you will join me in this effort by visiting ePsyQ.com supporting our efforts in whatever way you can. If you can only join Top Health Sites and display our banner on your site that's great! If you want to list your health service and/or spread the word about the FREE listing at eP... Ψ Dare To Dream... blogs http://www.medworm.com/rss/comments.php?id=4060797 Mon, 02 Oct 2006 03:26:57 +0100 4060797 http://www.medworm.com/index.php?rid=4060821&cid=t_232090_109_f&fid=34859&url=http%3A%2F%2Fblog.davemsw.com%2Farchives%2F2006%2F05%2Fscience_and_mass_media_dont_mi.php Sunday I found a disturbing article in a blog that has a good reputation. Dr. Peter Breggin at The Huffington Post wrote about the FDA decision to require a "black box" warning on the anti-depressant medication Paxil because of the risk of suicide in the beginning of treatment. Dr. Breggin is the author of the book Talking Back to Prozac which is highly critical of the anti-depressant medication Prozac. In his post at Huffington's, Dr. Breggin makes statements that appeared designed to attract attention at the expense of misleading the reader. I've written about the problem with reading articles about mental health in the press. Essentially, reader beware, what you read many be misinforming you. Sometimes misinformation occurs in the interest of selling a publication. Science has it's own ... Ψ Dare To Dream... blogs http://www.medworm.com/rss/comments.php?id=4060821 Tue, 23 May 2006 22:49:33 +0100 4060821 http://www.medworm.com/index.php?rid=4060847&cid=t_232090_109_f&fid=34859&url=http%3A%2F%2Fblog.davemsw.com%2Farchives%2F2006%2F03%2Fnews_reports_of_depression_stu.php Results of the STAR*D Part 1 Depression study by funded by NIMH was published in January in the American Journal of Psychiatry. Yesterday, the report on STAR*D Part 2 of the study was released, but requires a subscription. The press release summarizing the results is at the NIMH site. I found two reports in the press about the study. The Washington Post got it all wrong. Antidepressants fail to cure the symptoms of major depression in half of all patients with the disease even if they receive the best possible care, according to a definitive government study released yesterday. [...]Although the study showed that patients who do not respond well to one drug could be helped by another, the results are "discouraging for several reasons," Rubinow said in an editorial published in the New E... Ψ Dare To Dream... blogs http://www.medworm.com/rss/comments.php?id=4060847 Fri, 24 Mar 2006 03:20:57 +0100 4060847